These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 17136556

  • 1. [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].
    Multiple Sklerose Therapie Konsensus Gruppe (MSTKG), Rieckmann P.
    Nervenarzt; 2006 Dec; 77(12):1506-18. PubMed ID: 17136556
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G.
    Cochrane Database Syst Rev; 2013 Jun 06; 2013(6):CD008933. PubMed ID: 23744561
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.
    Fox RJ, Bethoux F, Goldman MD, Cohen JA.
    Cleve Clin J Med; 2006 Jan 06; 73(1):91-102. PubMed ID: 16444920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?
    Sorensen PS.
    Eur J Neurol; 2009 Mar 06; 16(3):287-8. PubMed ID: 19364360
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments.
    Sormani MP, Rovaris M, Bagnato F, Molyneux P, Bruzzi P, Pozzilli C, Miller DH, Comi G, Filippi M.
    Neurology; 2001 Nov 27; 57(10):1883-5. PubMed ID: 11723280
    [Abstract] [Full Text] [Related]

  • 15. Glatiramer acetate for the treatment of multiple sclerosis.
    Wolinsky JS.
    Expert Opin Pharmacother; 2004 Apr 27; 5(4):875-91. PubMed ID: 15102570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.
    Mult Scler; 2012 Aug 27; 18(8):1125-34. PubMed ID: 22194217
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.